Immune Thrombocytopenic Purpura in Patients with COVID-19
Sabine Revuz, Nathalie Vernier, Leilah Saadi and 3 more
European Journal of Case Reports in Internal Medicine · 2020
doi:10.12890/2020_001751 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
We described three COVID-19-infected patients with profound immune thrombocytopenia causing haemorrhagic mucocutaneous complications. We conclude that an immune mechanism was responsible as common causes were excluded. Since corticoids were considered harmful in the circumstances, the patients were successfully treated with intravenous immunoglobulins without later relapse.
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.